XML 81 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments - Narrative (Details)
12 Months Ended
Dec. 31, 2018
USD ($)
interest_rate_swap
Dec. 31, 2017
USD ($)
May 31, 2018
USD ($)
interest_rate_swap
Derivative [Line Items]      
Number of interest rate swaps held | interest_rate_swap 19    
Notional amount of derivative $ 29,742,000,000 $ 25,595,000,000  
Pre tax net unrealized gain (loss) on derivatives maturing within next 12 months estimated to be reclassified from AOCI to sales 186,000,000    
Equity investments without readily determinable fair values 568,000,000    
Unrealized gains based on favorable observable price changes 167,000,000    
Unrealized loss related to unfavorable observable price changes 26,000,000    
Available-for-sale debt securities included in Short-term investments 894,000,000    
Available-for-sale debt securities maturing within five years 5,800,000,000    
Cash and cash equivalents 7,965,000,000 6,092,000,000  
Payments of contingent consideration 244,000,000 100,000,000  
Fair value of loans payable and long-term debt, including current portion 25,600,000,000 25,600,000,000  
Carrying value of loans payable and long-term debt, including current portion 25,100,000,000 24,400,000,000  
Cash collateral received from counterparties $ 107,000,000 3,000,000  
Customer Concentration Risk | Accounts Receivable | McKesson Corporation, AmerisourceBergen Corporation and Cardinal Health, Inc. [Member]      
Derivative [Line Items]      
Percentage of accounts receivable represented by customers with largest balances (as percent) 40.00%    
Afferent Pharmaceuticals      
Derivative [Line Items]      
Payments of contingent consideration $ 175,000,000    
Significant Other Observable Inputs (Level 2)      
Derivative [Line Items]      
Cash and cash equivalents 8,000,000,000    
Cash equivalents $ 7,200,000,000    
1.30% notes due 2018 | Interest Rate Swap      
Derivative [Line Items]      
Number of interest rate swaps held | interest_rate_swap     4
Notional amount of derivative     $ 1,000,000,000
Face amount of debt     $ 1,000,000,000.0
Fixed-rate notes, stated interest rate (as percent)     1.30%
5.00% notes due 2019 | Interest Rate Swap      
Derivative [Line Items]      
Number of interest rate swaps held | interest_rate_swap 3    
Notional amount of derivative $ 550,000,000    
Face amount of debt $ 1,250,000,000.00    
Fixed-rate notes, stated interest rate (as percent) 5.00%    
Derivatives Designated as Hedging Instruments      
Derivative [Line Items]      
Notional amount of derivative $ 14,390,000,000 14,386,000,000  
Derivatives Not Designated as Hedging Instruments      
Derivative [Line Items]      
Notional amount of derivative $ 15,352,000,000 $ 11,209,000,000  
Maximum | Derivatives Designated as Hedging Instruments      
Derivative [Line Items]      
Maximum planning cycle of third-party sales hedges (no more than) 2 years    
Maximum | Derivatives Not Designated as Hedging Instruments      
Derivative [Line Items]      
Maximum planning cycle of third-party sales hedges (no more than) 1 year